Genetic Tech Spn ADR (GENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 12-2016 | 06-2016 | 12-2015 | 06-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 270 | 1,080 | N/A | 2,389 | N/A |
| Other Operating Activity | -3,070 | -6,710 | -3,200 | -10,496 | -4,980 |
| Operating Cash Flow | $-2,800 | $-5,630 | $-3,200 | $-8,107 | $-4,980 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 20 | -216 | -190 | -113 | -80 |
| Net Acquisitions | N/A | 0 | N/A | 1,757 | 1,790 |
| Investing Cash Flow | $20 | $-216 | $-190 | $1,644 | $1,710 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 5,310 | -1 | -1 | 19,128 | 1,890 |
| Financing Cash Flow | $5,310 | $-1 | $-1 | $19,128 | $1,890 |
| Exchange Rate Effect | 320 | 629 | 630 | 309 | 40 |
| Beginning Cash Position | 8,370 | 13,364 | 13,210 | 2,368 | 2,420 |
| End Cash Position | 11,240 | 8,146 | 10,460 | 15,343 | 1,090 |
| Net Cash Flow | $2,860 | $-5,218 | $-2,750 | $12,974 | $-1,330 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,800 | -5,630 | -3,200 | -8,107 | -4,980 |
| Free Cash Flow | -2,800 | -5,630 | -3,200 | -8,107 | -4,980 |